Program Details

The program below is subject to change. Please sign up for updates to be notified when information becomes available.  

PROGRAM - DAY 1 - Thursday 12 May 2022

Session 1: Opening Session

Chairs: John Atherton and Julie McGaughran

Time Talk Title  Speaker
0800-0810 Welcome John Atherton and Julie McGaughran,
Conference Co-Convenors
0810-0820 Official Opening   
0820-0830 Program highlights Chris Semsarian (NSW)
0830-0915 Personalised medicine in inherited cardiomyopathies Perry Elliott (UK)
0915-1000 Therapies for RASopathy related hypertrophic cardiomyopathy Bruce Gelb (USA)
1000-1030 Morning Break  

Session 2: What’s new in the inherited cardiomyopathies?




Time Talk Title Speaker
1030-1050 Arrhythmogenic cardiomyopathy: sorting the wheat from the chaff  
1050-1105 What’s new in HCM?


1105-1125 What’s new in DCM?  
1125-1140 What’s new in ACM?  
1140-1155 Cohort studies in the inherited cardiomyopathies  
Session 3: Genetic Testing for Familial hypercholesterolaemia
Time Talk Title Speaker 
1030-1045 Genetic testing and NHG Policy Framework  
1045-1100 The MSAC application and the MBS item  
1100-1115 The cardiology perspective  
1115-1130 What is the role of primary care?  
1130-1145 Implementation science: Making it happen  
1200-1330 Lunch  
Session 4: Latest in the inherited arrhythmia syndromes
Time Talk Title Speaker
1330-1350 Management pearls in CPVT  
1350-1405 Genotype-guided therapies in LQTS  
1405-1420 What is Brugada syndrome in 2022?  
1420-1435 Insights from iPSC models  
1435-1450 In vitro assessment of LQTS variants  
Session 5: Genetics in 2022
Time Talk Title Speaker
1330-1345 Polygenic risk scores in cardiovascular disease  
1345-1400 The role of genome sequencing


1400-1415 Gemonics and PRS in heart failure  
1415-1430 The need for population-specific reference databases  
1430-1445 Human cardiac organoids: An enabling
technology for functional genomics
1445-1500 Key role of the cardiac nurse in a cardiac genetic service   
1500-1530 Afternoon Break  
Session 6: Clinical, genetic and functional aspects of congenital heart disease


Time Talk Title Speaker
1530-1550 The genetic architecture of congenital heart disease  
1550-1605 Where next for broad-scale genetic testing in CHD?  
1605-1620 CHD genomics and gene discovery  
1620-1635 Pre-test genetic counselling: Preparing for universal whole genome sequencing  
1635-1650 Relevance of genetic investigations in childhood heart failure  
Conference Dinner
1900-2300 Conference Dinner, Level 12 Rooftop, Rydges South Bank Brisbane  



PROGRAM - DAY 2 - Friday 13 May 2022

Session 7: The great debate and oral abstract finalists
Chairs: Julie McGaughran and Chris Semsarian
Time Talk Title Speaker
0830-0915 Debate: Polygenic risk scores ready for cardiology clinic  
0915-1000 Abstract Prize Session   
0915-0930  Abstract Finalist 1   
0930-0945  Abstract Finalist 2   
0945-1000  Abstract Finalist 3   
1000-1030 Morning Break  
Session 8: Resuscitated sudden cardiac arrest in the young
Time Talk Title Speaker
1030-1045 Causes of sudden cardiac arrest in the young  
1045-1100 Investigation of a resuscitated cardiac arrest  
1100-1115 Progress in preventing malignant arrhythmias  
1115-1130 Sudden cardiac arrest in athletes: What’s different?  
1130-1145 Psychological support


Session 9: Latest advances in the familial aortopathies
Time Talk Title Speaker
1030-1045 What's new in the aortopathies  
1045-1100 Latest in the genetics of aortopathies  
1100-1115  Aortopathy findings at post-mortem  
1115-1130 Aortopathies in pregnancy  
1130-1150 Surgical approaches to aortopathies  
1200-1330 Lunch  
1215-1315 12x 5-min abstract presentations  
Session 10: National Collaborations and Case Presentations


Time Talk Title Speaker
1330-1350 The Australian Genomics Initiative  
1350-1400 The Cardiovascular Genetics Flagship - progress to date


1400-1430 Case Presentation #1 (Arrhythmia/SCD) Panel Members:


1430-1500 Case Presentation #2 (Cardiomyopathy)

Panel Members:


1500-1530 Afternoon Break  
Session 11: Final plenary


Time Talk Title Speaker
1530-1605  Precision medicine approach to congenital heart disease Bruce Gelb (USA)
1605-1640 Hypertrophic cardiomyopathy: What’s next? Perry Elliott (UK)
1640-1650 Thank you Chris Semsarian (NSW)
1650-1700 Official close of the Conference  John Atherton and Julie McGaughran,
Conference Co-Convenors